RUA Life Sciences plc (LON:RUA) Insider Purchases £3,250 in Stock

RUA Life Sciences plc (LON:RUA) insider William D. Brown bought 25,000 shares of the company’s stock in a transaction on Monday, February 3rd. The stock was purchased at an average cost of GBX 13 ($0.16) per share, for a total transaction of £3,250 ($4,063.01).

RUA Life Sciences Price Performance

Shares of LON:RUA opened at GBX 13.67 ($0.17) on Thursday. The company has a quick ratio of 7.32, a current ratio of 9.01 and a debt-to-equity ratio of 5.42. The stock has a market capitalization of £8.48 million, a PE ratio of -341.75 and a beta of 1.21. The firm’s 50 day moving average price is GBX 11.57 and its 200-day moving average price is GBX 11.74. RUA Life Sciences plc has a twelve month low of GBX 8.50 ($0.11) and a twelve month high of GBX 15.70 ($0.20).

RUA Life Sciences (LON:RUA) last released its quarterly earnings results on Wednesday, December 11th. The company reported GBX 1.03 ($0.01) earnings per share for the quarter. RUA Life Sciences had a negative net margin of 65.72% and a negative return on equity of 24.27%.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.